When are combination topical steroid and antiinfective products indicated? The combination products are often marginally effective and expensive. The most commonly prescribed products are Mycolog II (nystatin/triamcinolone) and Lotrisone (clotrimazole/betamethasone). Lotrisone is approved by the U.S. Food and Drug Administration (FDA) for tinea cruris/corporis/pedis in adults and children more than 12 years of age. Few nondermatology physicians recognize the steroid component to be fluorinated and high-/midpotency. They are also more likely to prescribe this product to children less than 5 years of age for use on genital skin. A baby’s diaper is occlusive, enhancing absorption, as well as the likelihood of side effects. Use of these products may lead to persistent and recurrent disease. Alston SJ, Cohen BA, Braun M: Persistent and recurrent tinea corporis in children treated with combination antifungal/ corticosteroid agents, Pediatrics 111(1):201–203, 2003. Railan D, Wilson JK, Feldman SR, Fleischer AB: Pediatricians who prescribe clotrimazole-betamethasone diproprionate (Lotrisone) often utilize it in inappropriate settings regardless of their knowledge of the drug’s potency, Dermatol Online J 8(2):3, 2002. Shaffer MP, Feldman SR, Fleischer AB Jr: Use of clotrimazole/ betamethasone diproprionate by family physicians, Fam Med 32(8):561–565, 2000. |
© 2024 Skin Disease & Care | All Rights Reserved.